Literature DB >> 18812405

2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features?

S Jaillard, C Dubourg, M Gérard-Blanluet, A Delahaye, L Pasquier, C Dupont, C Henry, A-C Tabet, J Lucas, A Aboura, V David, B Benzacken, S Odent, E Pipiras.   

Abstract

BACKGROUND: Genome-wide screening of patients with mental retardation using array comparative genomic hybridisation (CGH) has identified several novel imbalances. With this genotype-first approach, the 2q22.3q23.3 deletion was recently described as a novel microdeletion syndrome. The authors report two unrelated patients with a de novo interstitial deletion mapping in this genomic region and presenting similar "pseudo-Angelman" phenotypes, including severe psychomotor retardation, speech impairment, epilepsy, microcephaly, ataxia, and behavioural disabilities.
METHODS: The microdeletions were identified by array CGH using oligonucleotide and bacterial artificial chromosome (BAC) arrays, and further confirmed by fluorescence in situ hybridisation (FISH) and semi-quantitative polymerase chain reaction (PCR).
RESULTS: The boundaries and sizes of the deletions in the two patients were different but an overlapping region of about 250 kb was defined, which mapped to 2q23.1 and included two genes: MBD5 and EPC2. The SIP1 gene associated with the Mowat-Wilson syndrome was not included in the deleted genomic region. DISCUSSION: Haploinsufficiency of one of the deleted genes (MBD5 or EPC2) could be responsible for the common clinical features observed in the 2q23.1 microdeletion syndrome, and this hypothesis needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812405      PMCID: PMC3236717          DOI: 10.1136/jmg.2008.058156

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  31 in total

Review 1.  Genome architecture, rearrangements and genomic disorders.

Authors:  Paweł Stankiewicz; James R Lupski
Journal:  Trends Genet       Date:  2002-02       Impact factor: 11.639

2.  A novel microdeletion, del(2)(q22.3q23.3) in a mentally retarded patient, detected by array-based comparative genomic hybridization.

Authors:  D A Koolen; L E L M Vissers; W Nillesen; D Smeets; C M A van Ravenswaaij; E A Sistermans; J A Veltman; B B A de Vries; B D A de Vries
Journal:  Clin Genet       Date:  2004-05       Impact factor: 4.438

3.  Multiplex PCR/liquid chromatography assay for detection of gene rearrangements: application to RB1 gene.

Authors:  C Dehainault; A Laugé; V Caux-Moncoutier; S Pagès-Berhouet; F Doz; L Desjardins; J Couturier; M Gauthier-Villars; D Stoppa-Lyonnet; C Houdayer
Journal:  Nucleic Acids Res       Date:  2004-10-11       Impact factor: 16.971

4.  Interstitial deletion of the long arm of chromosome 2: a clinically recognizable microdeletion syndrome?

Authors:  S M Maas; J M Hoovers; M E van Seggelen; D M Menzel; R C Hennekam
Journal:  Clin Dysmorphol       Date:  2000-01       Impact factor: 0.816

5.  Clinical studies on submicroscopic subtelomeric rearrangements: a checklist.

Authors:  B B de Vries; S M White; S J Knight; R Regan; T Homfray; I D Young; M Super; C McKeown; M Splitt; O W Quarrell; A H Trainer; M F Niermeijer; S Malcolm; J Flint; J A Hurst; R M Winter
Journal:  J Med Genet       Date:  2001-03       Impact factor: 6.318

6.  KIF5C, a novel neuronal kinesin enriched in motor neurons.

Authors:  Y Kanai; Y Okada; Y Tanaka; A Harada; S Terada; N Hirokawa
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

7.  SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome.

Authors:  Gregor D Gilfillan; Kaja K Selmer; Ingrid Roxrud; Raffaella Smith; Mårten Kyllerman; Kristin Eiklid; Mette Kroken; Morten Mattingsdal; Thore Egeland; Harald Stenmark; Hans Sjøholm; Andres Server; Lena Samuelsson; Arnold Christianson; Patrick Tarpey; Annabel Whibley; Michael R Stratton; P Andrew Futreal; Jon Teague; Sarah Edkins; Jozef Gecz; Gillian Turner; F Lucy Raymond; Charles Schwartz; Roger E Stevenson; Dag E Undlien; Petter Strømme
Journal:  Am J Hum Genet       Date:  2008-03-13       Impact factor: 11.025

8.  Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans.

Authors:  Yannick Doyon; William Selleck; William S Lane; Song Tan; Jacques Côté
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

9.  Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities.

Authors:  Lisenka E L M Vissers; Bert B A de Vries; Kazutoyo Osoegawa; Irene M Janssen; Ton Feuth; Chik On Choy; Huub Straatman; Walter van der Vliet; Erik H L P G Huys; Anke van Rijk; Dominique Smeets; Conny M A van Ravenswaaij-Arts; Nine V Knoers; Ineke van der Burgt; Pieter J de Jong; Han G Brunner; Ad Geurts van Kessel; Eric F P M Schoenmakers; Joris A Veltman
Journal:  Am J Hum Genet       Date:  2003-11-18       Impact factor: 11.025

10.  Comparative study of methyl-CpG-binding domain proteins.

Authors:  Tim C Roloff; H Hilger Ropers; Ulrike A Nuber
Journal:  BMC Genomics       Date:  2003-01-16       Impact factor: 3.969

View more
  21 in total

1.  Severe intellectual disability and autistic features associated with microduplication 2q23.1.

Authors:  Brian H Y Chung; Sureni Mullegama; Christian R Marshall; Anath C Lionel; Rosanna Weksberg; Lucie Dupuis; Lauren Brick; Chumei Li; Stephen W Scherer; Swaroop Aradhya; D James Stavropoulos; Sarah H Elsea; Roberto Mendoza-Londono
Journal:  Eur J Hum Genet       Date:  2011-11-16       Impact factor: 4.246

2.  Outcome of array CGH analysis for 255 subjects with intellectual disability and search for candidate genes using bioinformatics.

Authors:  Y Qiao; C Harvard; C Tyson; X Liu; C Fawcett; P Pavlidis; J J A Holden; M E S Lewis; E Rajcan-Separovic
Journal:  Hum Genet       Date:  2010-05-29       Impact factor: 4.132

3.  Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability.

Authors:  Tjitske Kleefstra; Jamie M Kramer; Kornelia Neveling; Marjolein H Willemsen; Tom S Koemans; Lisenka E L M Vissers; Willemijn Wissink-Lindhout; Michaela Fenckova; Willem M R van den Akker; Nael Nadif Kasri; Willy M Nillesen; Trine Prescott; Robin D Clark; Koenraad Devriendt; Jeroen van Reeuwijk; Arjan P M de Brouwer; Christian Gilissen; Huiqing Zhou; Han G Brunner; Joris A Veltman; Annette Schenck; Hans van Bokhoven
Journal:  Am J Hum Genet       Date:  2012-06-21       Impact factor: 11.025

Review 4.  "Idiopathic" mental retardation and new chromosomal abnormalities.

Authors:  Cinzia Galasso; Adriana Lo-Castro; Nadia El-Malhany; Paolo Curatolo
Journal:  Ital J Pediatr       Date:  2010-02-14       Impact factor: 2.638

5.  Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder.

Authors:  Michael E Talkowski; Sureni V Mullegama; Jill A Rosenfeld; Bregje W M van Bon; Yiping Shen; Elena A Repnikova; Julie Gastier-Foster; Devon Lamb Thrush; Sekar Kathiresan; Douglas M Ruderfer; Colby Chiang; Carrie Hanscom; Carl Ernst; Amelia M Lindgren; Cynthia C Morton; Yu An; Caroline Astbury; Louise A Brueton; Klaske D Lichtenbelt; Lesley C Ades; Marco Fichera; Corrado Romano; Jeffrey W Innis; Charles A Williams; Dennis Bartholomew; Margot I Van Allen; Aditi Parikh; Lilei Zhang; Bai-Lin Wu; Robert E Pyatt; Stuart Schwartz; Lisa G Shaffer; Bert B A de Vries; James F Gusella; Sarah H Elsea
Journal:  Am J Hum Genet       Date:  2011-10-07       Impact factor: 11.025

6.  The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1.

Authors:  Holly N Cukier; Joycelyn M Lee; Deqiong Ma; Juan I Young; Vera Mayo; Brittany L Butler; Sandhya S Ramsook; Joseph A Rantus; Alexander J Abrams; Patrice L Whitehead; Harry H Wright; Ruth K Abramson; Jonathan L Haines; Michael L Cuccaro; Margaret A Pericak-Vance; John R Gilbert
Journal:  Autism Res       Date:  2012-10-10       Impact factor: 5.216

7.  MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes.

Authors:  Sureni V Mullegama; Loren Pugliesi; Brooke Burns; Zalak Shah; Raiha Tahir; Yanghong Gu; David L Nelson; Sarah H Elsea
Journal:  Eur J Hum Genet       Date:  2014-10-01       Impact factor: 4.246

8.  Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities.

Authors:  J C Hodge; E Mitchell; V Pillalamarri; T L Toler; F Bartel; H M Kearney; Y S Zou; W H Tan; C Hanscom; S Kirmani; R R Hanson; S A Skinner; R C Rogers; D B Everman; E Boyd; C Tapp; S V Mullegama; D Keelean-Fuller; C M Powell; S H Elsea; C C Morton; J F Gusella; B DuPont; A Chaubey; A E Lin; M E Talkowski
Journal:  Mol Psychiatry       Date:  2013-04-16       Impact factor: 15.992

9.  Extended spectrum of MBD5 mutations in neurodevelopmental disorders.

Authors:  Céline Bonnet; Asma Ali Khan; Emmanuel Bresso; Charlène Vigouroux; Mylène Béri; Sarah Lejczak; Bénédicte Deemer; Joris Andrieux; Christophe Philippe; Anne Moncla; Irina Giurgea; Marie-Dominique Devignes; Bruno Leheup; Philippe Jonveaux
Journal:  Eur J Hum Genet       Date:  2013-02-20       Impact factor: 4.246

Review 10.  Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND).

Authors:  Sureni V Mullegama; Sarah H Elsea
Journal:  Eur J Hum Genet       Date:  2016-05-25       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.